Masaru Matsuda is Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 150,641 shares of ARQT, which is worth approximately $3.77 Million. The most recent transaction as insider was on May 31, 2023, when has been sold 1,463 shares (Common Stock) at a price of $6.38 per share, resulting in proceeds of $9,333. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 151K
6.57% 3M change
19.46% 12M change
Total Value Held $3.77 Million

Masaru Matsuda Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2023
BUY
Grant, award, or other acquisition
$9,333 $6.38 p/Share
1,463 Added 3.25%
43,609 Common Stock
May 27 2023
BUY
Grant, award, or other acquisition
-
4,875 Added 9.98%
43,976 Common Stock
Mar 02 2023
SELL
Open market or private sale
$23,187 $16.17 p/Share
1,434 Reduced 7.34%
18,101 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
21,000 Added 34.94%
39,101 Common Stock
Nov 21 2022
SELL
Open market or private sale
$31,286 $18.19 p/Share
1,720 Reduced 8.09%
19,535 Common Stock
Nov 18 2022
BUY
Grant, award, or other acquisition
-
4,875 Added 18.66%
21,255 Common Stock
Jun 02 2022
SELL
Open market or private sale
$35,415 $19.73 p/Share
1,795 Reduced 9.88%
16,380 Common Stock
May 27 2022
BUY
Grant, award, or other acquisition
-
4,875 Added 21.15%
18,175 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
13,300 Added 50.0%
13,300 Common Stock

Also insider at

HALO
HALOZYME THERAPEUTICS, INC. Healthcare
MM

Masaru Matsuda

Officer
San Diego, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT